Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

Humanitas Clinical Institute of Rozzano, Milan, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:5City/State/Province:Milan
Treatments:ChemotherapyHospital:Humanitas Clinical Institute of Rozzano
Drugs:Journal:Link
Date:Apr 2008

Description:

Patients:
This study involved 30 malignant pleural mesothelioma patients with a median age of 66 years (range of 46-85). Of these, 73% were male.

Treatment:
Patients in this study were administered two chemotherapy agents, gemcitabine and vinorelbine. These agents block cancer cell division (growth).

Toxicities:
One death due to pneumonitis occurred during this study. Grade 3 or 4 neutropenia was experienced by 10% of the patients. Other grade 3 and 4 toxicities included fatigue, nausea, constipation, and diarrhea.

Results:
The median overall survival reported for this study was 10.9 months.

Correspondence: Dr. Paolo A. Zucali; email: [email protected]



Back